The neurotoxicity of nitrous oxide: The facts and "Putative" mechanisms

Brain Sciences

Volumn 4, Issue 1, 2014, Pages 73-90

  Savage, Sinead ^a   Ma, Daqing ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Homocysteine; Neurotoxicity; Nitrous oxide; NMDA antagonist

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; HOMOCYSTEINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITROUS OXIDE; REACTIVE OXYGEN METABOLITE;

ANESTHESIA; BRAIN BLOOD FLOW; CELL DAMAGE; DRUG MECHANISM; ENZYME INHIBITION; EXPOSURE; GABAERGIC TRANSMISSION; HUMAN; MITOCHONDRION; NERVE CELL DIFFERENTIATION; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; REVIEW; VULNERABLE POPULATION;

EID: 84937144953     PISSN: None     EISSN: 20763425     Source Type: Journal    
DOI: 10.3390/brainsci4010073     Document Type: Review

References (102)

1. Brotman, M.; Cullen, S.C. Supplementation with demerol during nitrous oxide anesthesia. Anesthesiology 1949, 10, 696-705.
2. Becker, D.E.; Rosenberg, M. Nitrous oxide and the inhalation anesthetics. Anesth. Prog. 2008, 55, 124-130.
3. Santos, M.; Kuncar, V.; Martinez-Taboada, F.; Tendillo, F.J. Large concentrations of nitrous oxide decrease the isoflurane minimum alveolar concentration sparing effect of morphine in the rat. Anesth. Analg. 2005, 100, 404-408.
4. Jakobsson, I.; Heidvall, M.; Davidson, S. The sevoflurane-sparing effect of nitrous oxide: A clinical study. Acta Anaesthesiol. Scand. 1999, 43, 411-414.
5. Carstoniu, J.; Levytam, S.; Norman, P.; Daley, D.; Katz, J.; Sandler, A.N. Nitrous oxide in early labor. Safety and analgesic efficacy assessed by a double-blind, placebo-controlled study. Anesthesiology 1994, 80, 30-35.
6. Leslie, K.; Myles, P.S.; Chan, M.T.; Forbes, A.; Paech, M.J.; Peyton, P.; Silbert, B.S.; Williamson, E. Nitrous oxide and long-term morbidity and mortality in the ENIGMA trial. Anesth. Analg. 2011, 112, 387-393.
7. Sanders, R.D.; Weimann, J.; Maze, M. Biologic effects of nitrous oxide: A mechanistic and toxicologic review. Anesthesiology 2008, 109, 707-722.
8. Myles, P.S.; Leslie, K.; Chan, M.T.; Forbes, A.; Paech, M.J.; Peyton, P.; Silbert, B.S.; Pascoe, E.; Group, E.T. Avoidance of nitrous oxide for patients undergoing major surgery: A randomized controlled trial. Anesthesiology 2007, 107, 221-231.
9. Truxell, E.M.; Molina, J.C.; Spear, N.E. Ethanol intake in the juvenile, adolescent, and adult rat: Effects of age and prior exposure to ethanol. Alcohol. Clin. Exp. Res. 2007, 31, 755-765.
10. Clancy, B.; Finlay, B.L.; Darlington, R.B.; Anand, K.J. Extrapolating brain development from experimental species to humans. Neurotoxicology 2007, 28, 931-937.
11. Lu, L.X.; Yon, J.H.; Carter, L.B.; Jevtovic-Todorovic, V. General anesthesia activates BDNF-dependent neuroapoptosis in the developing rat brain. Apoptosis 2006, 11, 1603-1615.
12. Jevtovic-Todorovic, V.; Hartman, R.E.; Izumi, Y.; Benshoff, N.D.; Dikranian, K.; Zorumski, C.F.; Olney, J.W.; Wozniak, D.F. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J. Neurosci. 2003, 23, 876-882.
13. Shu, Y.; Patel, S.M.; Pac-Soo, C.; Fidalgo, A.R.; Wan, Y.; Maze, M.; Ma, D. Xenon pretreatment attenuates anesthetic-induced apoptosis in the developing brain in comparison with nitrous oxide and hypoxia. Anesthesiology 2010, 113, 360-368.
14. Ikonomidou, C. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999, 283, 70-74.
15. Monyer, H.; Burnashev, N.; Laurie, D.J.; Sakmann, B.; Seeburg, P.H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 1994, 12, 529-540.
16. Yon, J.H.; Daniel-Johnson, J.; Carter, L.B.; Jevtovic-Todorovic, V. Anesthesia induces neuronal cell death in the developing rat brain via the intrinsic and extrinsic apoptotic pathways. Neuroscience 2005, 135, 815-827.
17. Shu, Y.; Zhou, Z.; Wan, Y.; Sanders, R.D.; Li, M.; Pac-Soo, C.K.; Maze, M.; Ma, D. Nociceptive stimuli enhance anesthetic-induced neuroapoptosis in the rat developing brain. Neurobiol. Dis. 2012, 45, 743-750.
18. Yon, J.H.; Carter, L.B.; Reiter, R.J.; Jevtovic-Todorovic, V. Melatonin reduces the severity of anesthesia-induced apoptotic neurodegeneration in the developing rat brain. Neurobiol. Dis. 2006, 21, 522-530.
19. Beals, J.K.; Carter, L.B.; Jevtovic-Todorovic, V. Neurotoxicity of nitrous oxide and ketamine is more severe in aged than in young rat brain. Ann. N. Y. Acad. Sci. 2003, 993, 123-124.
20. Culley, D.J.; Baxter, M.G.; Yukhananov, R.; Crosby, G. Long-term impairment of acquisition of a spatial memory task following isoflurane-nitrous oxide anesthesia in rats. Anesthesiology 2004, 100, 309-314.
21. Culley, D.J.; Raghavan, S.V.; Waly, M.; Baxter, M.G.; Yukhananov, R.; Deth, R.C.; Crosby, G. Nitrous oxide decreases cortical methionine synthase transiently but produces lasting memory impairment in aged rats. Anesth. Analg. 2007, 105, 83-88.
22. Culley, D.J.; Baxter, M.; Yukhananov, R.; Crosby, G. The memory effects of general anesthesia persist for weeks in young and aged rats. Anesth. Analg. 2003, 96, 1004-1009.
23. Zou, X.; Liu, F.; Zhang, X.; Patterson, T.A.; Callicott, R.; Liu, S.; Hanig, J.P.; Paule, M.G.; Slikker, W., Jr.; Wang, C. Inhalation anesthetic-induced neuronal damage in the developing rhesus monkey. Neurotoxicol. Teratol. 2011, 33, 592-597.
24. Wang, C.; Sadovova, N.; Hotchkiss, C.; Fu, X.; Scallet, A.C.; Patterson, T.A.; Hanig, J.; Paule, M.G.; Slikker, W., Jr. Blockade of N-methyl-D-aspartate receptors by ketamine produces loss of postnatal day 3 monkey frontal cortical neurons in culture. Toxicol. Sci. 2006, 91, 192-201.
25. Slikker, W., Jr.; Zou, X.; Hotchkiss, C.E.; Divine, R.L.; Sadovova, N.; Twaddle, N.C.; Doerge, D.R.; Scallet, A.C.; Patterson, T.A.; Hanig, J.P.; et al. Ketamine-induced neuronal cell death in the perinatal rhesus monkey. Toxicol. Sci. 2007, 98, 145-158.
26. Paule, M.G.; Li, M.; Allen, R.R.; Liu, F.; Zou, X.; Hotchkiss, C.; Hanig, J.P.; Patterson, T.A.; Slikker, W., Jr.; Wang, C. Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys. Neurotoxicol. Teratol. 2011, 33, 220-230.
27. Loepke, A.W.; Soriano, S.G. An assessment of the effects of general anesthetics on developing brain structure and neurocognitive function. Anesth. Analg. 2008, 106, 1681-1707.
28. Hollmen, A.I.; Jouppila, R.; Koivisto, M.; Maatta, L.; Pihlajaniemi, R.; Puukka, M.; Rantakyla, P. Neurologic activity of infants following anesthesia for cesarean section. Anesthesiology 1978, 48, 350-356.
29. Noguchi, K.K.; Nemmers, B.; Farber, N.B. Age has a similar influence on the susceptibility to NMDA antagonist-induced neurodegeneration in most brain regions. Brain Res. Dev. Brain Res. 2005, 158, 82-91.
30. Jevtovic-Todorovic, V.; Todorovic, S.M.; Mennerick, S.; Powell, S.; Dikranian, K.; Benshoff, N.; Zorumski, C.F.; Olney, J.W. Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat. Med. 1998, 4, 460-463.
31. Jevtovic-Todorovic, V.; Beals, J.; Benshoff, N.; Olney, J.W. Prolonged exposure to inhalational anesthetic nitrous oxide kills neurons in adult rat brain. Neuroscience 2003, 122, 609-616.
32. Royston, B.D.; Nunn, J.F.; Weinbren, H.K.; Royston, D.; Cormack, R.S. Rate of inactivation of human and rodent hepatic methionine synthase by nitrous oxide. Anesthesiology 1988, 68, 213-216.
33. 2O). Mutat. Res. 2012, 731, 58-63.
34. Chen, Y.; Liu, X.; Cheng, C.H.; Gin, T.; Leslie, K.; Myles, P.; Chan, M.T. Leukocyte DNA damage and wound infection after nitrous oxide administration: A randomized controlled trial. Anesthesiology 2013, 118, 1322-1331.
35. Selzer, R.R.; Rosenblatt, D.S.; Laxova, R.; Hogan, K. Adverse effect of nitrous oxide in a child with 5,10-methylenetetrahydrofolate reductase deficiency. N. Engl. J. Med. 2003, 349, 45-50.
36. Singer, M.A.; Lazaridis, C.; Nations, S.P.; Wolfe, G.I. Reversible nitrous oxide-induced myeloneuropathy with pernicious anemia: Case report and literature review. Muscle Nerve 2008, 37, 125-129.
37. Berkowitz, B.A.; Finck, A.D.; Ngai, S.H. Nitrous oxide analgesia: Reversal by naloxone and development of tolerance. J. Pharmacol. Exp. Ther. 1977, 203, 539-547.
38. Branda, E.M.; Ramza, J.T.; Cahill, F.J.; Tseng, L.F.; Quock, R.M. Role of brain dynorphin in nitrous oxide antinociception in mice. Pharmacol. Biochem. Behav. 2000, 65, 217-221.
39. Quock, R.M.; Best, J.A.; Chen, D.C.; Vaughn, L.K.; Portoghese, P.S.; Takemori, A.E. Mediation of nitrous oxide analgesia in mice by spinal and supraspinal kappa-opioid receptors. Eur. J. Pharmacol. 1990, 175, 97-100.
40. Hodges, B.L.; Gagnon, M.J.; Gillespie, T.R.; Breneisen, J.R.; O'Leary, D.F.; Hara, S.; Quock, R.M. Antagonism of nitrous oxide antinociception in the rat hot plate test by site-specific mu and epsilon opioid receptor blockade. J. Pharmacol. Exp. Ther. 1994, 269, 596-600.
41. Ori, C.; Fordrice, F.; London, E.D. Effects of nitrous-oxide and halothane on mu-opioid and kappa-opioid receptors in guinea-pig brain. Anesthesiology 1989, 70, 541-544.
42. Orestes, P.; Bojadzic, D.; Lee, J.; Leach, E.; Salajegheh, R.; Digruccio, M.R.; Nelson, M.T.; Todorovic, S.M. Free radical signalling underlies inhibition of CaV3.2 T-type calcium channels by nitrous oxide in the pain pathway. J. Physiol. 2011, 589, 135-148.
43. 2O) requires the N-methyl-D-aspartate receptor for its action in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 2004, 101, 8791-8796.
44. + channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol. Pharmacol. 2004, 65, 443-452.
45. + channels-molecular sensors. Biochim. Biophys. Acta 2002, 1566, 152-161.
46. + channel involved in neuroprotection and general anesthesia. EMBO J. 2004, 23, 2684-2695.
47. + channel involved in polymodal pain perception. EMBO J. 2006, 25, 2368-2376.
48. Safari, A.; Emadi, F.; Jamali, E.; Borhani-Haghighi, A. Clinical and MRI manifestations of nitrous oxide induced vitamin B12 deficiency: A case report. Iran J. Neurol. 2013, 12, 111-113.
49. Hsu, C.K.; Chen, Y.Q.; Lung, V.Z.; His, S.C.; Lo, H.C.; Shyu, H.Y. Myelopathy and polyneuropathy caused by nitrous oxide toxicity: A case report. Am. J. Emerg. Med. 2012, 30, 1016. e3-1016. e6.
50. Lin, R.J.; Chen, H.F.; Chang, Y.C.; Su, J.J. Subacute combined degeneration caused by nitrous oxide intoxication: Case reports. Acta Neurol. Taiwanica 2011, 20, 129-137.
51. Cheng, H.M.; Park, J.H.; Hernstadt, D. Subacute combined degeneration of the spinal cord following recreational nitrous oxide use. BMJ Case Rep. 2013, doi:10.1136/bcr-2012-008509.
52. Sotirchos, E.S.; Saidha, S.; Becker, D. Neurological picture. Nitrous oxide-induced myelopathy with inverted V-sign on spinal MRI. J. Neurol. Neurosurg. Psychiatry 2012, 83, 915-916.
53. Abraini, J.H.; David, H.N.; Nicole, O.; MacKenzie, E.T.; Buisson, A.; Lemaire, M. Neuroprotection by nitrous oxide and xenon and its relation to minimum alveolar concentration. Anesthesiology 2004, 101, 260-261.
54. David, H.N.; Leveille, F.; Chazalviel, L.; MacKenzie, E.T.; Buisson, A.; Lemaire, M.; Abraini, J.H. Reduction of ischemic brain damage by nitrous oxide and xenon. J. Cereb. Blood Flow Metab. 2003, 23, 1168-1173.
55. Haelewyn, B.; David, H.N.; Rouillon, C.; Chazalviel, L.; Lecocq, M.; Risso, J.J.; Lemaire, M.; Abraini, J.H. Neuroprotection by nitrous oxide: Facts and evidence. Crit. Care Med. 2008, 36, 2651-2659.
56. Haelewyn, B.; David, H.N.; Colloc'h, N.; Colomb, D.G., Jr.; Risso, J.J.; Abraini, J.H. Interactions between nitrous oxide and tissue plasminogen activator in a rat model of thromboembolic stroke. Anesthesiology 2011, 115, 1044-1053.
57. Wong, E.H.; Kemp, J.A.; Priestley, T.; Knight, A.R.; Woodruff, G.N.; Iversen, L.L. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. USA 1986, 83, 7104-7108.
58. McNamara, J.O.; Russell, R.D.; Rigsbee, L.; Bonhaus, D.W. Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models. Neuropharmacology 1988, 27, 563-568.
59. Fix, A.S.; Horn, J.W.; Wightman, K.A.; Johnson, C.A.; Long, G.G.; Storts, R.W.; Farber, N.; Wozniak, D.F.; Olney, J.W. Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): A light and electron microscopic evaluation of the rat retrosplenial cortex. Exp. Neurol. 1993, 123, 204-215.
60. Wiescholleck, V.; Manahan-Vaughan, D. Long-lasting changes in hippocampal synaptic plasticity and cognition in an animal model of NMDA receptor dysfunction in psychosis. Neuropharmacology 2013, 74, 48-58.
61. Giovannini, M.G.; Mutolo, D.; Bianchi, L.; Michelassi, A.; Pepeu, G. NMDA receptor antagonists decrease GABA outflow from the septum and increase acetylcholine outflow from the hippocampus: A microdialysis study. J. Neurosci. 1994, 14, 1358-1365.
62. Kim, S.H.; Price, M.T.; Olney, J.W.; Farber, N.B. Excessive cerebrocortical release of acetylcholine induced by NMDA antagonists is reduced by GABAergic and alpha2-adrenergic agonists. Mol. Psychiatry 1999, 4, 344-352.
63. Shichino, T.; Murakawa, M.; Adachi, T.; Arai, T.; Miyazaki, Y.; Mori, K. Effects of inhalation anaesthetics on the release of acetylcholine in the rat cerebral cortex in vivo. Br. J. Anaesth. 1998, 80, 365-370.
64. Strominger, N.L.; Hori, N.; Carpenter, D.O.; Tan, Y.; Folger, W.H. Effects of acetylcholine and GABA on neurons in the area postrema of Suncus murinus brainstem slices. Neurosci. Lett. 2001, 309, 77-80.
65. Olney, J.W.; Newcomer, J.W.; Farber, N.B. NMDA receptor hypofunction model of schizophrenia. J. Psychiatr. Res. 1999, 33, 523-533.
66. Wozniak, D.F.; Dikranian, K.; Ishimaru, M.J.; Nardi, A.; Corso, T.D.; Tenkova, T.; Olney, J.W.; Fix, A.S. Disseminated corticolimbic neuronal degeneration induced in rat brain by MK-801: Potential relevance to Alzheimer's disease. Neurobiol. Dis. 1998, 5, 305-322.
67. Newcomer, J.W.; Farber, N.B.; Jevtovic-Todorovic, V.; Selke, G.; Melson, A.K.; Hershey, T.; Craft, S.; Olney, J.W. Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 1999, 20, 106-118.
68. Homayoun, H.; Moghaddam, B. NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J. Neurosci. 2007, 27, 11496-11500.
69. Javitt, D.C. Glutamatergic theories of schizophrenia. Isr. J. Psychiatry Relat. Sci. 2010, 47, 4-16.
70. Nunn, J.F. Clinical aspects of the interaction between nitrous oxide and vitamin B12. Br. J. Anaesth. 1987, 59, 3-13.
71. Mayer, E.L.; Jacobsen, D.W.; Robinson, K. Homocysteine and coronary atherosclerosis. J. Am. Coll. Cardiol. 1996, 27, 517-527.
72. Blacher, J.; Demuth, K.; Guerin, A.P.; Vadez, C.; Moatti, N.; Safar, M.E.; London, G.M. Association between plasma homocysteine concentrations and cardiac hypertrophy in end-stage renal disease. J. Nephrol. 1999, 12, 248-255.
73. Badner, N.H.; Drader, K.; Freeman, D.; Spence, J.D. The use of intraoperative nitrous oxide leads to postoperative increases in plasma homocysteine. Anesth. Analg. 1998, 87, 711-713.
74. Nagele, P.; Tallchief, D.; Blood, J.; Sharma, A.; Kharasch, E.D. Nitrous oxide anesthesia and plasma homocysteine in adolescents. Anesth. Analg. 2011, 113, 843-848.
75. Nappo, F.; de Rosa, N.; Marfella, R.; de Lucia, D.; Ingrosso, D.; Perna, A.F.; Farzati, B.; Giugliano, D. Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA 1999, 281, 2113-2118.
76. Ermens, A.A.; Refsum, H.; Rupreht, J.; Spijkers, L.J.; Guttormsen, A.B.; Lindemans, J.; Ueland, P.M.; Abels, J. Monitoring cobalamin inactivation during nitrous oxide anesthesia by determination of homocysteine and folate in plasma and urine. Clin. Pharmacol. Ther. 1991, 49, 385-393.
77. Badner, N.H.; Freeman, D.; Spence, J.D. Preoperative oral B vitamins prevent nitrous oxide-induced postoperative plasma homocysteine increases. Anesth. Analg. 2001, 93, 1507-1510.
78. Lipton, S.A.; Kim, W.K.; Choi, Y.B.; Kumar, S.; D'Emilia, D.M.; Rayudu, P.V.; Arnelle, D.R.; Stamler, J.S. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc. Natl. Acad. Sci. USA 1997, 94, 5923-5928.
79. Seshadri, S. Elevated plasma homocysteine levels: Risk factor or risk marker for the development of dementia and Alzheimer's disease? J. Alzheimers Dis. 2006, 9, 393-398.
80. Troen, A.M.; Shea-Budgell, M.; Shukitt-Hale, B.; Smith, D.E.; Selhub, J.; Rosenberg, I.H. B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice. Proc. Natl. Acad. Sci. USA 2008, 105, 12474-12479.
81. Nagele, P.; Zeugswetter, B.; Wiener, C.; Burger, H.; Hupfl, M.; Mittlbock, M.; Fodinger, M. Influence of methylenetetrahydrofolate reductase gene polymorphisms on homocysteine concentrations after nitrous oxide anesthesia. Anesthesiology 2008, 109, 36-43.
82. Nygard, O.; Vollset, S.E.; Refsum, H.; Stensvold, I.; Tverdal, A.; Nordrehaug, J.E.; Ueland, M.; Kvale, G. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995, 274, 1526-1533.
83. Lafon-Cazal, M.; Pietri, S.; Culcasi, M.; Bockaert, J. NMDA-dependent superoxide production and neurotoxicity. Nature 1993, 364, 535-537.
84. Akaike, A.; Katsuki, H.; Kume, T.; Maeda, T. Reactive oxygen species in NMDA receptor-mediated glutamate neurotoxicity. Parkinsonism Relat. Disord. 1999, 5, 203-207.
85. Reynolds, I.J.; Hastings, T.G. Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J. Neurosci. 1995, 15, 3318-3327.
86. Dugan, L.L.; Sensi, S.L.; Canzoniero, L.M.; Handran, S.D.; Rothman, S.M.; Lin, T.S.; Goldberg, M.P.; Choi, D.W. Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J. Neurosci. 1995, 15, 6377-6388.
87. Gordeeva, A.V.; Zvyagilskaya, R.A.; Labas, Y.A. Cross-talk between reactive oxygen species and calcium in living cells. Biochemistry 2003, 68, 1077-1080.
88. Hernandez-Fonseca, K.; Cardenas-Rodriguez, N.; Pedraza-Chaverri, J.; Massieu, L. Calcium-dependent production of reactive oxygen species is involved in neuronal damage induced during glycolysis inhibition in cultured hippocampal neurons. J. Neurosci. Res. 2008, 86, 1768-1780.
89. Peng, T.I.; Jou, M.J. Oxidative stress caused by mitochondrial calcium overload. Ann. N. Y. Acad. Sci. 2010, 1201, 183-188.
90. Adam-Vizi, V.; Starkov, A.A. Calcium and mitochondrial reactive oxygen species generation: How to read the facts. J. Alzheimers Dis. 2010, 20, S413-S426.
91. Herrmann, W.; Obeid, R. Homocysteine: A biomarker in neurodegenerative diseases. Clin. Chem. Lab. Med. 2011, 49, 435-441.
92. Zhuo, J.M.; Wang, H.; Pratico, D. Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither? Trends Pharmacol. Sci. 2011, 32, 562-571.
93. Zieminska, E.; Lazarewicz, J.W. Excitotoxic neuronal injury in chronic homocysteine neurotoxicity studied in vitro: The role of NMDA and group I metabotropic glutamate receptors. Acta Neurobiol. Exp. 2006, 66, 301-309.
94. 2+ signaling. Am. J. Physiol. Cell Physiol. 2006, 291, C1082-C1088.
95. Boscolo, A.; Starr, J.A.; Sanchez, V.; Lunardi, N.; DiGruccio, M.R.; Ori, C.; Erisir, A.; Trimmer, P.; Bennett, J.; Jevtovic-Todorovic, V. The abolishment of anesthesia-induced cognitive impairment by timely protection of mitochondria in the developing rat brain: The importance of free oxygen radicals and mitochondrial integrity. Neurobiol. Dis. 2012, 45, 1031-1041.
96. Zhen, Y.; Dong, Y.; Wu, X.; Xu, Z.; Lu, Y.; Zhang, Y.; Norton, D.; Tian, M.; Li, S.; Xie, Z. Nitrous oxide plus isoflurane induces apoptosis and increases beta-amyloid protein levels. Anesthesiology 2009, 111, 741-752.
97. Ben-Ari, Y. Excitatory actions of gaba during development: The nature of the nurture. Nat. Rev. Neurosci. 2002, 3, 728-739.
98. Herlenius, E.; Lagercrantz, H. Development of neurotransmitter systems during critical periods. Exp. Neurol. 2004, 190, S8-S21.
99. Murawska-Cialowicz, E.; Januszewska, L.; Zuwala-Jagiello, J.; Milczarska, J.; Zawadzki, M.; Paprocka-Borowicz, M.; Wierzbicka-Damska, I. Melatonin decreases homocysteine level in blood of rats. J. Physiol. Pharmacol. 2008, 59, 717-729.
100. Baydas, G.; Koz, S.T.; Tuzcu, M.; Nedzvetsky, V.S. Melatonin prevents gestational hyperhomocysteinemia-associated alterations in neurobehavioral developments in rats. J. Pineal Res. 2008, 44, 181-188.
101. Hancock, S.M.; Nathanson, M.H. Nitrous oxide or remifentanil for the "at risk" brain. Anaesthesia 2004, 59, 313-315.
102. Volmanen, P.; Akural, E.; Raudaskoski, T.; Ohtonen, P.; Alahuhta, S. Comparison of remifentanil and nitrous oxide in labour analgesia. Acta Anaesthesiol. Scand. 2005, 49, 453-458.